Frequently Asked Questions
The market is segmented based on , By Drug Type (Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids, and Others), Anatomy (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, and Others), Route of Administration (Parenteral Route, Topical Route, and Oral Route), Sales Channel (Prescription Drugs and Over-the-Counter Drugs), End-use (Hospital Pharmacies, Retail Pharmacies, and Others) – Industry Trends and Forecast to 2031.
.
The Global Osteoarthritis Therapeutics Market size was valued at USD 7.96 USD Billion in 2023.
The Global Osteoarthritis Therapeutics Market is projected to grow at a CAGR of 9% during the forecast period of 2024 to 2031.
The major players operating in the market include Pfizer Inc. (U.S.), Abbvie Inc. (U.S.), Novartis AG (Switzerland), Amgen Inc. (U.S.), Boehringer Ingelheim International GmbH (Germany), Samsung Bioepis (South Korea), Merck & Co. Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceuticals Industries Ltd. (Israel), AstraZeneca PLC (U.K.), Zimmer Biomet (U.S.), and Stryker Corporation (U.S.).
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
